Your search for

23 results were returned

  1. Generic_icon
    01 December 2020
    Patent Linkage Scheme in Singapore - Recent Developments
    www.twobirds.com/en/events/singapore/2020/patent-linkage-scheme-in-singapore-recent-developments

    As part of the patent linkage scheme in Singapore, applicants for registration of a therapeutic product in Singapore must declare whether there is a patent in force in respect of the therapeutic product. Whilst there ...

  2. Legal news
    30 September 2019
    Bird & Bird secures win in preliminary injunction patent case before the Düsseldorf Courts
    www.twobirds.com/en/news/articles/2019/germany/bird-and-bird-secures-win-in-preliminary-injunction-patent-case-before-the-dusseldorf-courts

    On September 26, 2019, the Higher Regional Court of Düsseldorf confirmed on appeal that Teva Pharmaceutical Industries Ltd. (“Teva”) – one of Bird & Bird’s key clients – is entitled to a preliminary injunction against ...

  3. Legal news
    06 September 2019
    China passed new amendments to the Drug Administration Law
    www.twobirds.com/en/news/articles/2019/global/china-passed-new-amendments-to-the-drug-administration-law

    On 26 August 2019, China's National People's Congress passed the final amendments to the Drug Administration Law ("DAL"), which will take effect on 1 December 2019. The DAL was first enacted in 1984, then substantively ...

  4. Legal news
    24 May 2019
    Can CRISPR save the Cavendish?
    www.twobirds.com/en/news/articles/2019/global/can-crispr-save-the-cavendish

    The world's most popular banana is dying. Scientists are using the gene-editing mechanism CRISPR to try and save it from extinction.

  5. Legal news
    16 September 2020
    NMPA and CNIPA issue Draft Patent Linkage Measures in China
    www.twobirds.com/en/news/articles/2020/china/nmpa-and-cnipa-issue-draft-patent-linkage-measures-in-china

    On 11 September 2020, the National Medical Products Administration ("NMPA") and the China National Intellectual Property Administration ("CNIPA") issued the draft "Implementing Measures for Drug Patent Dispute Early ...

  6. Legal news
    03 August 2020
    China Updates Drug Registration Rules and the Measures for Monitoring Drug Production – Part 2
    www.twobirds.com/en/news/articles/2020/china/china-updates-drug-registration-rules-and-the-measures-for-monitoring-drug

    The restating of the expedited review pathways, and the recently published work procedures, appear to be a step toward improving a process that has seemingly changed numerous times over the years.

  7. Legal news
    15 October 2020
    Patent linkage scheme in Singapore – A process patent can be "A patent in respect of the therapeutic product"
    www.twobirds.com/en/news/articles/2020/singapore/patent-linkage-scheme-in-singapore

    In Singapore, pursuant to the Health Products (Therapeutic Products) Regulations 2016, applicants for registration of a therapeutic product in Singapore must declare whether "a patent is in force in respect of the ...

  8. Legal news
    04 November 2020
    Chinese patent linkage system - the Chinese Supreme Court issues Draft Judicial Interpretations
    www.twobirds.com/en/news/articles/2020/china/chinese-patent-linkage-system---the-chinese-supreme-court-issues-draft-judicial-interpretations

    As the patent linkage provisions are new for China, the Draft Judicial Interpretations provide some guidance on how the system will be implemented in practice. The Draft Judicial Interpretations are open for public ...

  9. Legal news
    08 May 2019
    Manufacturing and stockpiling waiver set to limit rights of holders of SPCs for medicines
    www.twobirds.com/en/news/articles/2019/global/manufacturing-and-stockpiling-waiver-set-to-limit-rights-of-holders-of-spcs-for-medicines

    On 17 April 2019, the European Parliament approved, by a large majority, an amendment of the Regulation on Supplementary Protection Certificates ("SPCs").

  10. Legal news
    27 March 2019
    Supreme Court holds Dosage Regime Patent Obvious
    www.twobirds.com/en/news/articles/2019/global/supreme-court-holds-dosage-regime-patent-obvious

    Today in Actavis v ICOS the Supreme Court unanimously ruled that the ICOS patent for a Tadalafil dosing regime was invalid. Lord Hodge gave the only judgment, with Lady Hale, Lord Kerr, Lord Sumption and Lord Briggs in ...